Glenmark starts Phase-3 clinical trials on antiviral drug Favipiravir for COVID-19 clients in India
Glenmark Pharmaceuticals has initiated Phase-3 clinical trials in India on antiviral tablet Favipiravir, for which it received approval from India’s…
- Tue. Nov 5th, 2024
Latest News